BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37318606)

  • 21. Nomogram integrating gene expression signatures with clinicopathological features to predict survival in operable NSCLC: a pooled analysis of 2164 patients.
    Wu J; Zhou L; Huang L; Gu J; Li S; Liu B; Feng J; Zhou Y
    J Exp Clin Cancer Res; 2017 Jan; 36(1):4. PubMed ID: 28057025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Prediction Rule for Overall Survival in Non-Small-Cell Lung Cancer Patients with a Pathological Tumor Size Less Than 30 mm.
    Zhu WY; Fang KX; He JY; Cui R; Zhang YK; Le HB
    Dis Markers; 2019; 2019():8435893. PubMed ID: 31191756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.
    Yu G; Liu X; Li Y; Zhang Y; Yan R; Zhu L; Wang Z
    Front Public Health; 2022; 10():946299. PubMed ID: 36159305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and Validation of a Novel Survival Prediction Model in Patients With Spinal Metastasis From Non-small Cell Lung Cancer.
    Yang M; Xu W; Liu T; Yang X; Wang P; Wu S; Wei H; Zhao J; Yang C; Xiao J
    Spine (Phila Pa 1976); 2019 Feb; 44(4):246-257. PubMed ID: 30059487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A predictive model based on liquid biopsy for non-small cell lung cancer to assess patient's prognosis: Development and application.
    Gu T; Ren J; Hu Z; Wei Y; Huang J
    Tissue Cell; 2022 Aug; 77():101854. PubMed ID: 35752028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer.
    Zeng Y; Mayne N; Yang CJ; D'Amico TA; Ng CSH; Liu CC; Petersen RH; Rocco G; Brunelli A; Liu J; Liu Y; Huang W; He J; Wang W; Jiang L; Cui F; Wang W; Liang W; He J;
    Ann Surg Oncol; 2019 Jul; 26(7):2053-2062. PubMed ID: 30900105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
    Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
    Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of prognostic nomogram for T
    Mei W; Yao W; Song Z; Jiao W; Zhu L; Huang Q; An C; Shi J; Yu G; Sun P; Zhang Y; Shen J; Xu C; Yang H; Wang Q; Zhu Z
    BMC Cancer; 2023 Jul; 23(1):715. PubMed ID: 37525124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced non small cell lung cancer: response to microwave ablation and EGFR Status.
    Wei Z; Ye X; Yang X; Huang G; Li W; Wang J; Han X; Meng M; Ni Y
    Eur Radiol; 2017 Apr; 27(4):1685-1694. PubMed ID: 27436020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.
    An C; Wu S; Huang Z; Ni J; Zuo M; Gu Y; Zhang T; Huang J
    Cancer Med; 2020 Jan; 9(1):104-115. PubMed ID: 31714685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma.
    Duijm M; Oomen-de Hoop E; van Voort van der Zyp N; van de Vaart P; Tekatli H; Hoogeman M; Senan S; Nuyttens J
    Radiother Oncol; 2021 Mar; 156():223-230. PubMed ID: 33418006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study.
    Liu Y; Sun M; Xiong Y; Gu X; Zhang K; Liu L
    Technol Cancer Res Treat; 2022; 21():15330338221132035. PubMed ID: 36217877
    [No Abstract]   [Full Text] [Related]  

  • 34. Construction and validation of a novel prognostic nomogram for predicting overall survival in lung adenocarcinoma patients with different patterns of metastasis.
    Xiong Y; Gu F; Cui J; Liu Y; Sun M; Gu X; Zhong L; Zhang K; Liu L
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15039-15053. PubMed ID: 37612389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study.
    Ni Y; Bi J; Ye X; Fan W; Yu G; Yang X; Huang G; Li W; Wang J; Han X; Ni X; Wei Z; Han M; Zheng A; Meng M; Xue G; Zhang L; Wan C
    Medicine (Baltimore); 2016 Jun; 95(25):e3998. PubMed ID: 27336903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and Validation of a Nomogram for Predicting Progression- Free Survival in Patients with Early-Stage Testicular Germ Cell Tumor.
    Chen JG; Wang JQ; Peng TW; Chen ZS; Zhao SC
    Recent Pat Anticancer Drug Discov; 2021; 16(1):44-53. PubMed ID: 33573563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
    Li H; Wang Z; Yang F; Wang J
    J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Construction of a nomogram model for predicting 2-year survival rate of small cell lung cancer based on more comprehensive variables].
    Wei LJ; Hou Q; Yao NN; Liang Y; Cao X; Sun BC; Li HW; Liu JT; Xu SM; Cao J
    Zhonghua Yi Xue Za Zhi; 2022 May; 102(17):1283-1289. PubMed ID: 35488697
    [No Abstract]   [Full Text] [Related]  

  • 39. Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: a study based on the SEER database and a Chinese cohort.
    Zhou L; Zhang Y; Chen W; Niu N; Zhao J; Qi W; Xu Y
    BMC Cancer; 2022 Sep; 22(1):980. PubMed ID: 36104656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and an External Validation Cohort.
    Zuo Z; Zhang G; Song P; Yang J; Li S; Zhong Z; Tan Q; Wang L; Xue Q; Gao S; Sun N; He J
    Ann Surg Oncol; 2021 Jul; 28(7):3941-3950. PubMed ID: 33249521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.